Stock listing
VM4 Stock Price, News, Filings & Events — Vanda Pharmaceuticals Inc.
Selected listing: VM4 · BX · CHF · CH
This page tracks Vanda Pharmaceuticals Inc.'s VM4:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VM4:BX. VM4:BX is the stock-level entry point for investors researching Vanda Pharmaceuticals Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vanda Pharmaceuticals Inc. (Ticker: VNDA) is a public company based in America, focused on developing and commercializing innovative therapies for patients with unmet medical needs. The company has a market capitalization of approximately $311.5 million. Vanda's portfolio includes treatments for sleep disorders and other conditions, highlighting its commitment to addressing significant health challenges.
- Ticker
- VM4:BX
- Asset type
- Stock
- Market cap
- $319.2M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BX
- Currency
- CHF
Vanda Pharmaceuticals Inc. VM4:BX stock context
This page tracks Vanda Pharmaceuticals Inc.'s VM4:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VM4:BX. VM4:BX is the stock-level entry point for investors researching Vanda Pharmaceuticals Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vanda Pharmaceuticals Inc. (Ticker: VNDA) is a public company based in America, focused on developing and commercializing innovative therapies for patients with unmet medical needs. The company has a market capitalization of approximately $311.5 million. Vanda's portfolio includes treatments for sleep disorders and other conditions, highlighting its commitment to addressing significant health challenges.
Latest news from Vanda Pharmaceuticals Inc.
NEREUS™ Sponsored No. 47 IndyCar Ready for Historic Freedom 250 Grand Prix in Washington, D.C.
August 22, 2026
Vanda Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 5, 2026
July 29, 2026
Vanda Pharmaceuticals Announces EMA Positive Opinion for Orphan Drug Designation of Imsidolimab for Generalized Pustular Psoriasis - A Mi...
July 16, 2026
NEREUS™ Powers Forward: Sponsors No. 47 IndyCar Entry, Celebrating 47 Years Since Last New U.S. Motion Sickness Treatment
July 15, 2026
Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle & Vision Summit
July 10, 2026
Research Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. investor report
Review AI stock analysis and investor report context for VM4:BX.
Vanda Pharmaceuticals Inc. company profile
View the public company page for Vanda Pharmaceuticals Inc. on 6ix.
Vanda Pharmaceuticals Inc. news
Read company news and market updates connected to Vanda Pharmaceuticals Inc..
Vanda Pharmaceuticals Inc. investor events
Find investor webinars, events, and replay context for Vanda Pharmaceuticals Inc..
Alternate listings
VNDA:NASDAQ
US · USD
Alternate listing for Vanda Pharmaceuticals Inc.; the primary context on this page is VM4:BX.
VM4:GETTEX
DE · EUR
Alternate listing for Vanda Pharmaceuticals Inc.; the primary context on this page is VM4:BX.
VNDA:BOATS
US · USD
Alternate listing for Vanda Pharmaceuticals Inc.; the primary context on this page is VM4:BX.
A0JJT3:LS
DE · EUR
Alternate listing for Vanda Pharmaceuticals Inc.; the primary context on this page is VM4:BX.
A0JJT3:LSX
DE · EUR
Alternate listing for Vanda Pharmaceuticals Inc.; the primary context on this page is VM4:BX.
0LKB:LSE
GB · USD
Alternate listing for Vanda Pharmaceuticals Inc.; the primary context on this page is VM4:BX.
VM4:FWB
DE · EUR
Alternate listing for Vanda Pharmaceuticals Inc.; the primary context on this page is VM4:BX.
VM4:DUS
DE · EUR
Alternate listing for Vanda Pharmaceuticals Inc.; the primary context on this page is VM4:BX.
VM4:SWB
DE · EUR
Alternate listing for Vanda Pharmaceuticals Inc.; the primary context on this page is VM4:BX.
VM4:TRADEGATE
DE · EUR
Alternate listing for Vanda Pharmaceuticals Inc.; the primary context on this page is VM4:BX.